Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma

BACKGROUND: Advanced cholangiocellular carcinoma has a poor prognosis with limited therapeutic options. Nab-paclitaxel has recently been described to be beneficial in metastatic pancreatic cancer improving overall and progression free survival (PFS). The potential antitumor activity of nab-paclitaxe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Gastrointest Oncol
Main Authors: Unseld, Matthias, Scheithauer, Werner, Weigl, Roman, Kornek, Gabriela, Stranzl, Nadja, Bianconi, Daniela, Brunauer, Georg, Steger, Guenther, Zielinski, Christoph C., Prager, Gerald W.
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963366/
https://ncbi.nlm.nih.gov/pubmed/27563449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.05.01
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki